Attovia Therapeutics, Inc（ATTO）美股招股说明书 S-1（2026-07-29修订版）（英文版）（298页）.pdf

1、S-1/A 1 d40469ds1a.htm S-1/AAs filed with the Securities and Exchange Commission on July 29,2026.Registration No.333-297452UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549AMENDMENT NO.1TOFORM S-1REGISTRATION STATEMENTUnderThe Securities Act of 1933ATTOVIA THERAPEUTICS,INC.(Exact n

2、ame of Registrant as specified in its charter)Delaware 2836 92-1510574(State or other jurisdiction ofincorporation or organization)(Primary Standard IndustrialClassification Code Number)(I.R.S.EmployerIdentification Number)1091 Industrial Road,Suite 310San Carlos,California 94070(510)399-5001(Addres

3、s,including zip code,and telephone number,including area code,of registrants principal executive offices)Tao FuChief Executive Officer1091 Industrial Road,Suite 310San Carlos,California 94070(510)399-5001(Name,address,including zip code,and telephone number,including area code,of agent for service)C

4、opies to:Matthew Rossiter,Esq.Robert A.Freedman,Esq.Amanda Rose,Esq.Chelsea Anderson,Esq.Fenwick&West LLPOne Front Street33rd FloorSan Francisco,California 94111(415)875-2300 Charles S.Kim,Esq.Kristin VanderPas,Esq.Denny Won,Esq.Dave PeinsippCooley LLP10265 Science Center DriveSan Diego,California 9

5、2121(858)550-6000Approximate date of commencement of proposed sale to the public:As soon as practicable after the effective date of this registration statement.If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Sec

6、urities Act of 1933 check the followingbox.If this Form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities Act,please check the following box and list the Securities Actregistration statement number of the earlier effective registration statement f